1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Roopa Industries Limited

Roopa Industries Limited

ROOPAIND.BO
Roopa Industries LimitedIN flagBombay Stock Exchange
49.99
INR
- -
- -
393.20MMarket Cap
Roopa Industries Limited
ROOPAIND.BO
(Bombay Stock Exchange)

Recent

price

49.99

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
47.25
45.96
40.88
36.3
39.38
38.91
38.07
23.32
37.76
34.22
36.16
65.1
96.84
89.54
152.42
- -
161.67
Revenue per Share
0.72
0.88
0.22
-2.55
0.2
0.22
0.24
0.69
0.77
0.47
0.91
1.29
1.72
1.93
2.57
- -
0.11
Basic EPS, GAAP
0.75
0.04
-2.11
0.48
0.56
1.62
-1.95
-8.84
2.21
2.47
-1.6
1.91
-2.21
1.55
-9.4
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
12.58
13.36
12.8
10.23
10.44
10.31
10.3
10.3
10.3
10.3
10.3
10.3
17
18.94
21.38
- -
9.97
Book Value per Share
13.39
14.06
13.36
10.79
11
11.52
11.9
12.48
13.25
13.73
14.7
16
17.73
19.67
22.09
- -
22.31
Tangible Book Value per Share
7
7
8
8
8
8
8
8
8
8
8
8
8
8
8
- -
8
Basic Weighted Avg Shares
319
326
321
286
310
306
299
183
297
269
284
512
762
704
1,207
1,275
1,275
Sales/Revenue/Turnover
3.66
6.08
3.36
-2.71
5.17
5.33
7.85
-17.18
6.72
7.46
7.04
5.3
4.39
5.22
2.7
5.77
5.77
Operating Margin (%)
4
5
6
6
7
5
5
5
6
8
8
9
9
9
9
8
8
Depreciation Expense
5
6
2
-20
2
2
2
5
6
4
7
10
13
15
20
1
1
Net Income, GAAP
24.9
29.23
42.05
- -
8.93
35.15
55.92
- -
23.49
53.5
23.2
25.38
25.31
30.12
25.23
50.89
50.89
Effective Tax Rate (%)
1.52
1.91
0.55
-7.03
0.52
0.56
0.63
2.94
2.03
1.38
2.52
1.98
1.77
2.16
1.69
0.07
0.07
Profit Margin (%)
75
39
39
17
34
65
101
117
97
86
99
73
29
61
165
128
128
Working Capital
55
28
24
27
34
49
70
101
95
74
78
41
20
53
69
25
25
LT Debt
90
100
105
85
87
91
94
98
104
108
116
126
139
155
175
176
176
Total Equity
6.26
9.55
4
- -
8.89
6.25
5.55
- -
6.09
3.85
6.3
8.1
8.58
6.8
5.14
7.14
7.14
Return on Invested Capital (%)
3.57
4.4
1.15
- -
4.64
4.43
3.75
- -
6
3.79
6.49
8.5
9.05
8.2
9.14
3.74
3.74
Return on Capital (%)
6.01
6.95
1.79
-22.17
1.98
2.1
2.32
6.66
7.46
4.59
8.84
12.53
12.57
10.75
12.79
0.67
0.67
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
315
- -
286
LT Borrowings
46
- -
25
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
- -
8
Market Capitalization
428
350
309

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
778
- -
632
Cash, Cash Equivalents & STI
17
- -
15
Accounts Receivable, Net
164
- -
219
Inventories
350
- -
308
Total Current Liabilities
625
- -
504
Payables & Accruals
- -
- -
- -
ST Debt
315
- -
286
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.93%
8.85%
0.58%
Free Cash Flow
-161.75%
-294.36%
-155.89%
Net Income, GAAP
28.8%
5.06%
-95.92%
Sales/Revenue/Turnover
21.56%
39.66%
5.65%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
150
141
192
221
704
2025
345
256
307
298
1,207
2026
351
287
335
301
1,275

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.25
0.77
0.34
- -
1.93
2025
0.35
0.74
0.97
0.51
2.57
2026
0.36
0.59
0.98
-1.8
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Quest Laboratories Ltd. (QUESTLAB.NS)
CTT Pharmaceutical Holdings, Inc. (CTTH)
Tsuruha Holdings Inc. (TSUSF)
Syschem (India) Limited (SYSCHEM.BO)
POMDOCTOR Ltd (POM)
Biofrontera Inc. (BFRI)
Business
Roopa Industries Limited manufactures and markets active pharmaceutical ingredients, pharmaceutical intermediates, nutraceuticals, bulk drugs, and fine chemicals in India and internationally; core products include triphenyl phosphine for cephalosporin antibiotics, statins, specialty resins, paints, fire retardants, phosphonium salts, phase transfer catalysts, and agricultural applications; glucosamine as a nutritional supplement for arthritis treatment; bromine and its derivatives such as meta bromo anisole, tetra butyl ammonium bromide, 1-bromo-3-chloropropane, and 1-acetoxy ethyl bromide for agro chemicals, dyes, organic and inorganic intermediates, medical and veterinary products, gasoline applications, water purification, disinfectants, insecticides, pesticides, and mercury decontamination; N,N-dicyclohexylcarbodiimide; and 5-cyano phthalide. The company, founded in 1985 and headquartered in Hyderabad, India, with manufacturing facilities in Patancheru and Adoni in Andhra Pradesh, employs over 150 qualified staff including a research and development division and serves global customers with customized requirements through world-class infrastructure. Roopa Industries maintains operations in the chemicals and pharmaceuticals sectors targeting pharmaceutical manufacturers, nutraceutical producers, and industrial chemical users; it recently experienced a fire incident in a storage room for raw materials, work-in-progress, and finished goods at its Patancheru plant on November 3, 2025.